13.

SHARE-BASED COMPENSATION:

 

The Company has one active stock incentive plan for employees and directors, the 2022 Stock Incentive Plan, which provides for awards of stock options to purchase shares of common stock, stock appreciation rights, restricted and unrestricted shares of common stock, RSUs, and PSAs. In addition, the Company had one inactive stock incentive plan, the 2007 Stock Incentive Plan, under which the last awards granted vested on April 1, 2024.

 

The following table summarizes share-based compensation expense recorded (in thousands):

 

  

Year Ended December 31,

 
  

2025

  

2024

  

2023

 
             

Cost of sales

 $1,338  $1,511  $1,027 

Selling, general, and administrative expense

  4,226   3,550   2,645 

Total

 $5,564  $5,061  $3,672 

 

There were 453,641 shares of common stock available for future issuance under the Company’s stock incentive plan as of December 31, 2025, assuming the outstanding PSAs vest at the target level of 100%.

 

Restricted Stock Units and Performance Share Awards

 

The Company’s stock incentive plan provides for equity instruments, such as RSUs and PSAs, which grant the right to receive a specified number of shares at specified times. RSUs and PSAs are service-based awards that vest according to the terms of the grant. PSAs have performance-based payout conditions.

 

The following table summarizes the Company’s RSU and PSA activity:

 

  

Number of RSUs and PSAs (1)

  

Weighted- Average Grant Date Fair Value

 
         

Unvested RSUs and PSAs as of December 31, 2024

  240,071  $31.89 

RSUs and PSAs granted

  107,065   42.41 

RSUs and PSAs vested (2)

  (117,339)  31.24 

Unvested RSUs and PSAs as of December 31, 2025

  229,797   37.12 

 

 

(1)

The number of PSAs disclosed in this table are at the target level of 100%.

   
 (2)For the PSAs vested on March 31, 2025, the actual number of common shares that were issued was determined by multiplying the PSAs at the target level of 100%, as disclosed in this table, by a payout percentage based on the performance-based conditions achieved. The payout percentage was 118% for the 2022-2024 performance period, 111% for the 2023-2024 performance period, and 133% for the 2024 performance period.

 

The unvested balance of RSUs and PSAs as of December 31, 2025 includes approximately 172,000 PSAs at the target level of 100%. The vesting of these awards is subject to the achievement of specified performance-based conditions, and the actual number of common shares that will ultimately be issued will be determined by multiplying this number of PSAs by a payout percentage ranging from 0 to 200%.

 

The weighted-average grant date fair value of RSUs and PSAs granted during the years ended December 31, 2025, 2024, and 2023 was $42.41, $34.68, and $28.41, respectively. The total fair value of RSUs and PSAs vested during the years ended December 31, 2025, 2024, and 2023 was $6.3 million, $4.1 million, and $4.4 million, respectively.

 

Based on the estimated level of achievement of the performance targets associated with the PSAs as of December 31, 2025, unrecognized compensation expense related to the unvested portion of the Company’s RSUs and PSAs was $4.1 million, which is expected to be recognized over a weighted-average period of 1.5 years.

 

Stock Awards

 

For the years ended December 31, 2025, 2024, and 2023, stock awards of 12,996 shares, 14,424 shares, and 15,904 shares, respectively, were granted to non-employee directors, which vested immediately upon issuance. The Company recorded compensation expense based on the weighted-average fair market value per share of the awards on the grant date of $39.23 in 2025, $33.27 in 2024, and $29.51 in 2023.

 

Historical Timeline

Fiscal YearFiled
2025Feb 26, 2026Showing above
2024Feb 27, 2025
2023Mar 5, 2024
2022Mar 16, 2023
2021Mar 16, 2022
2020Mar 4, 2021
2019Mar 3, 2020
2018Mar 15, 2019
2017Mar 16, 2018
2016Mar 9, 2017
2015Mar 4, 2016

About Stock Compensation Disclosures

Stock-based compensation disclosures detail the equity awards granted to employees and executives — including stock options, restricted stock units (RSUs), and performance shares — along with the valuation methods and assumptions used to expense them. This section reveals the true cost of talent retention and the alignment between management incentives and shareholder interests.

Key signals: total unrecognized compensation expense and its expected recognition period signal future earnings headwinds from already-granted awards. For stock options, examine Black-Scholes assumptions — expected volatility, risk-free rate, and expected term — as understating any of these reduces reported compensation expense. Compare stock compensation expense as a percentage of revenue against peers to assess dilution cost. Watch vesting schedules for acceleration clauses tied to change-of-control events. Performance-based awards with undemanding targets may indicate weak governance. Add back stock compensation to operating cash flow to calculate a more conservative free cash flow figure.